Engineered bacteria can be used in gut therapies, but maintaining control over their colonization and genetic stability remains challenging.
The next wave of gut health products won’t just claim to be natural — they’ll be microbiome-powered and science-certified.
Probiotics protect against obesity and inflammation caused by high sugar intake, supporting their use as a preventive strategy for obesity-related diabetes.
Mahesh Desai, group leader of the Eco-Immunology and Microbiome team at the Luxembourg Institute of Health and adjunct associate professor at the University of Southern Denmark, discusses about his research…
The race toward evidence-based microbiome nutrition has just found its new headquarters.
Maternal oral microbiota plays a key role in influencing infant gut health and disease risk.
A recent study highlights formate as a potential target to boost cancer treatment.
The company is now taking a decisive step from laboratory-scale research to industrial-scale biofermentation.
Recent studies have identified various bacterial and fungal pathobionts in patients with CD and UC.
Patrick Veiga, Gut Microbiome & Nutrition Research Director at INRAE (France), discusses one of the major challenges in probiotic research: the variability of clinical trial outcomes.
